ProFuse Technology is proud to announce:
A remarkable technology for the enhancement of human skeletal muscle cell differentiation, fusion & maturation
Human iPSC - derived myoblast differentiation
(72 hours post treatment)
ProFuse technology significantly enhances the differentiation, fusion, and maturation of human muscle progenitor cells. The resulting differentiated cells closely resemble native human skeletal muscle fibers, making them an invaluable tool for a wide range of research and development applications, including muscle disease modeling.
ProFuse Enhances Myoblast
Fusion
and Myotube Maturity Levels
The iPSC-derived myotubes using ProFuse’s technology demonstrate a significantly higher level of maturity compared to the benchmark. Key parameters including fusion index, relative fiber width, and area coverage are substantially increased. The resulting myotubes show proper expression of key sarcomeric proteins, indicating a more advanced state of maturation. This leads to the generation of more biologically relevant muscle tissue in a significantly shorter timeframe.